The FDA also previously highlighted impurity and API characterization concerns for BPC-157 and MOTs-C and an absence of human exposure data for KPV
Symptoms tend to be milder than in other types of CHI, manifesting as unprovoked convulsions, low muscle tone, a decline of response, drowsiness, etc
In addition, its recommended that they be used within 14 days of preparation and discarded shortly thereafter if not used immediately
Most formulations are administered via subcutaneous injection (except oral semaglutide), typically weekly or daily depending on the specific medication, with dosing gradually increased over several weeks to minimize gastrointestinal side effects and optimize therapeutic response
It belongs in every hyperpigmentation routine, every morning, regardless of what else you are using